References

1. Harris EN, Phil M, Chan JKH et al. Thrombosis, recurrent fetal loss and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med. 1986; 146(11):2153-2156. PubMed | Google Scholar


2. Roubey Ra, Hoffman M. From antiphospholipid syndrome to antibody-mediated thrombosis. The Lancet.1997; 350(9090):1491-1493. PubMed | Google Scholar


3. Piette Jc, Amoura Z, Wechsler B et al. Manifestations neurologiques du syndrome des antiphospholipides. Rev Med Interne. 1998; (19):39S-45S. PubMed | Google Scholar


4. Greaves M. Antiphospholipid antibodies and thrombosis. The Lancet. 1999; 353(9161):1348-1353. PubMed | Google Scholar


5. Nzerue CM, Hewan-Lowe K, Pierangeli S, Harris EN. "Black swan in the kidney": renal involvement in the antiphospholipid antibody syndrome. Kidney Int. 2002; 62(3):733-744. PubMed | Google Scholar


6. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2):295-306. PubMed | Google Scholar


7. Wahl D, Saadi L, Perret-Guillaume C, Membre A, Frederic M, Devignes J. Syndrome des antiphospholipides : classification actuelle et indications thérapeutiques. Med Ther. 2007;13(2):1-11. Google Scholar


8. Pengo V, Ruffatti A, Legnani C, Testa S, Fierro T, Marongiu F et al. Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. Blood. 2011; 118 (17):4714-4718. PubMed | Google Scholar


9. Nochy DE, Daugas E, Droz D, Beaufils H, Grunfeld JP, Piette JC et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol. 1999; 10(3):507-518. PubMed | Google Scholar


10. Saadoun D, Piette J-C, Wahl D, Costedoat-Chalumeau N. Management of antiphospholipid syndrome. Rev Med Interne. 2012; 33(4):217-222. PubMed